… most highly cited articles? Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST … Moiseev et al   Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience …

… collaborations across stakeholders in the field of CAR T-cell therapies. The selection committee was composed by … selection committee: The Role of Bridging Therapy before CAR-T Cell Therapy in Diffuse Large B-cell Lymphoma: An …

… there are 826,174 patients, 942,848 transplants, 20,036 CAR-T treatments, 8,572 Immunosuppressive Treatments and 98 Gene …

… TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome Oral … responses leading to ICANS (Neurotoxicity associated with CAR T cell therapy) and ultimately improve immunotherapies. …

… of the EBMT meetings, including the Annual Meetings and CAR-T Meetings where I have presented and chaired sessions. I …

… st dedicated trainee session at the EBMT-EHA 4 th European CAR T-cell meeting in collaboration with Young EHA March 2022 -1 … over the next few months and plans for a Paediatric and CAR-T e-course this year EBMT Trainee Podcasts - now up to 25 …

… experience  with cytopenias and organ toxicities post CAR-T therapies. On the basis of these two studies the process of … preparation was started to address cytopenia after CAR-T. TCWP conducted a successful educational meeting in …

… experience with cytopenias and organ complications after CAR-T therapies as well as the first AI study conducted in the …

… Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies ” published in Blood .   * … refractory patients, including chimeric antigen receptor (CAR) T-cell therapies and bispecific antibodies (BsAbs) as … of recently approved T-cell redirection therapies, such as CAR T-cells and BsAbs, to improve patient outcomes. In R/R FL …

… this achievement? Anti-cluster of differentiation (CD)19 CAR-T cell therapy is the standard of care treatment for patients … choose for individual patients. Given the frequent use of CAR-T cells today, this could significantly impact the …